Symbiotec Pharma shares jump 8% after US FDA report on Pithampur plant

Shares of Symbiotec Pharmalab rose 8.53% to ₹1,145.80 on Tuesday (September 29) after the pharmaceutical company said it had received an Establishment Inspection Report from the US Food and Drug Administration (FDA) for its manufacturing facility in Pithampur, Madhya Pradesh.The stock closed at ₹1…